Colorado Springs, COLORADO10 Active Studies

Interstitial Cystitis Clinical Trials in Colorado Springs, COLORADO

Find 10 actively recruiting interstitial cystitis clinical trials in Colorado Springs, COLORADO. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
3,184
Enrolling

Recruiting Interstitial Cystitis Studies in Colorado Springs

RecruitingColorado Springs, COLORADONCT05600777

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC)....

975 participants
Bellus Health Inc. - a GSK company
View Study Details
RecruitingColorado Springs, COLORADONCT05156398

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine....

640 participants
Pfizer
View Study Details
RecruitingColorado Springs, COLORADONCT06339008

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to...

450 participants
Eli Lilly and Company
View Study Details
RecruitingColorado Springs, COLORADONCT07043400

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

This study is designed to assess the levels of drug exposure following treatment with tislelizumab administered as a subcutaneous (SC) injection compared to intravenous infusion (IV) as first-line the...

351 participants
BeiGene
View Study Details
RecruitingColorado Springs, COLORADONCT05976243

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension (OLE). The purpose of the core period (52 weeks o...

348 participants
Novartis Pharmaceuticals
View Study Details
RecruitingColorado Springs, COLORADONCT06116916

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME....

150 participants
Kyowa Kirin Co., Ltd.
View Study Details
RecruitingColorado Springs, COLORADONCT06843590

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

The purpose of this study is to measure the safety and decrease in daytime sleepiness in subjects with Idiopathic Hypersomnia when taking ALKS 2680 tablets compared with placebo tablets...

96 participants
Alkermes, Inc.
View Study Details
RecruitingColorado Springs, COLORADONCT06850805

Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps

This is a 12-Week randomized, double-blind, placebo-controlled, parallel-group, multicenter study evaluating the efficacy and safety of intranasal administration of 186 µg of OPN-375 twice a day (BID)...

84 participants
Optinose US Inc.
View Study Details
RecruitingColorado Springs, COLORADONCT06165341

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

The liver produces a protein called alpha-1 antitrypsin (AAT). AAT is normally released into the bloodstream. In some people, the liver makes an abnormal version of the AAT protein, called Z-AAT. Maki...

50 participants
Takeda
View Study Details
RecruitingColorado Springs, COLORADONCT06812078

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

Idiopathic Hypersomnia (IH) is a condition where people feel extremely sleepy during the day, especially in the morning, even if they sleep a lot at night. They may have trouble waking up in the morni...

40 participants
Takeda
View Study Details

About Interstitial Cystitis Clinical Trials in Colorado Springs

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 10 interstitial cystitis clinical trials recruiting participants in Colorado Springs, COLORADO. These studies are seeking a combined 3,184 participants. Research is being sponsored by Bellus Health Inc. - a GSK company, Pfizer, Eli Lilly and Company and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Colorado Springs — FAQ

Are there interstitial cystitis clinical trials in Colorado Springs?

Yes, there are 10 interstitial cystitis clinical trials currently recruiting in Colorado Springs, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 10 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov